Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

NCT00791895 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S